EP3672975
CONDENSED HETEROCYCLIC DERIVATIVES AS BCL-2 INHIBITORS FOR THE TREATMENT OF NEOPLASTIC DISEASES
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
22.8.2018EP published:
12.4.2023EP application number:
18765254.0
EPO information:
European Patent Register
Max expiry date:
21.8.2038
Title in English:
CONDENSED HETEROCYCLIC DERIVATIVES AS BCL-2 INHIBITORS FOR THE TREATMENT OF NEOPLASTIC DISEASESLanguage of the patent:
English
Timeline
Today
22.8.2018EP application
12.4.2023EP Publication
Owner
Name:
Guangzhou Lupeng Pharmaceutical Company Ltd.Address:
Room 322, Building B Shilian Science Park No. 33 Science Avenue Huangpu District, Guangzhou City, GuangDong Province, CN
Inventor
Name:
CHEN, YiAddress:
Pleasanton, CA 94566, US
Name:
LOU, YanAddress:
Pleasanton, CA 94566, US
Priority
Number:
201762549081 PDate:
23.8.2017Country:
US
Number:
201862615007 PDate:
9.1.2018Country:
US
Classification
Categories:
C07D 498/14, C07D 513/14, A61P 35/00, A61P 37/00, A61K 31/553, A61K 31/554